Aeternum Health Inc.
AETN
$0.15
-$0.01-6.45%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 226.81% | 264.39% | 400.00% | 1,133.88% | 216.24% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 226.81% | 264.39% | 400.00% | 1,133.88% | 216.24% |
| Cost of Revenue | 24.18% | 30.58% | 134.87% | 60.68% | 57.85% |
| Gross Profit | 2,411.54% | 1,056.14% | 6,946.67% | 506.94% | 77.29% |
| SG&A Expenses | -29.23% | -19.73% | -20.32% | -7.05% | 58.12% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -23.42% | -14.27% | -8.61% | -0.30% | 58.01% |
| Operating Income | 51.50% | 41.92% | 40.88% | 40.86% | -49.72% |
| Income Before Tax | 27.30% | 11.87% | 52.28% | 50.62% | 26.70% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 27.30% | 11.87% | 52.28% | 50.62% | 26.70% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 27.30% | 11.87% | 52.28% | 50.62% | 26.70% |
| EBIT | 51.50% | 41.92% | 40.88% | 40.86% | -49.72% |
| EBITDA | -- | -- | -- | -- | 37.20% |
| EPS Basic | 28.13% | 11.36% | 51.82% | 50.36% | 17.24% |
| Normalized Basic EPS | 43.42% | 32.39% | 47.37% | 44.74% | -61.70% |
| EPS Diluted | 34.91% | 20.41% | 55.10% | 53.74% | 10.17% |
| Normalized Diluted EPS | 43.42% | 32.39% | 47.37% | 44.74% | -61.70% |
| Average Basic Shares Outstanding | 1.17% | -0.22% | -0.43% | -0.26% | -36.95% |
| Average Diluted Shares Outstanding | 1.17% | -0.22% | -0.43% | -0.26% | -36.95% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |